Prostatic artery embolization for giant prostatic hyperplasia: a single-center experience
| Autor: | Airton Mota Moreira, André Moreira de Assis, Francisco Cesar Carnevale, José Ramón Lanz-Luces |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Quality of life
medicine.medical_specialty Embolização terapêutica Urology R895-920 Single Center 030218 nuclear medicine & medical imaging 03 medical and health sciences Qualidade de vida Medical physics. Medical radiology. Nuclear medicine 0302 clinical medicine Prostate Lower urinary tract symptoms Medicine Prostatic hyperplasia/diagnostic imaging Radiology Nuclear Medicine and imaging Hiperplasia prostática/diagnóstico por imagem Embolization therapeutic Índice de gravidade de doença business.industry Retrospective cohort study Hyperplasia medicine.disease Prostatic artery embolization Próstata/irrigação sanguínea Prostate-specific antigen Prostate/blood supply medicine.anatomical_structure Severity of illness index 030220 oncology & carcinogenesis International Prostate Symptom Score Original Article Sintomas do trato urinário inferior business |
| Zdroj: | Radiologia Brasileira, Vol 54, Iss 4, Pp 219-224 (2021) Radiologia Brasileira Radiologia Brasileira v.54 n.4 2021 Colégio Brasileiro de Radiologia e Diagnóstico por Imagem (CBR) instacron:CBR |
| ISSN: | 1678-7099 |
| Popis: | To describe the safety and efficacy of prostatic artery embolization (PAE) in patients with a markedly enlarged prostate.This was a retrospective study including 18 consecutive patients (mean age, 74 years) with benign prostatic hyperplasia, all with a prostate volume ≥ 200 cmThe PAE procedure was technically successful in 17 patients (94.4%). During follow-up, clinical failure (defined as an International Prostate Symptom Score [IPSS] ≥ 8) was observed in two (11.1%) of those 18 patients. At 3 months of follow-up, there was significant improvement over baseline in all relevant outcome measures: total IPSS (from 15.7 to 2.9); IPSS quality of life score (from 5.2 to 1.0); prostate specific antigen (from 11.4 to 1.82 ng/mL); peak urinary flow rate (from 7.45 to 18.6 mL/s); prostate volume (from 252.4 to 151.6 cmIn patients with a markedly enlarged prostate, PAE proved to be safe and effective, resulting in significant improvements in clinical, imaging, and urodynamic parameters.Descrever a segurança e eficácia da embolização das artérias prostáticas (EAP) em pacientes com próstatas muito aumentadas (≥ 200 cmEste estudo retrospectivo incluiu 18 pacientes consecutivos com hiperplasia prostática benigna portadores de próstatas ≥ 200 cmA EAP foi tecnicamente bem-sucedida em 17 pacientes (94,4%). Falha clínica (IPSS ≥ 8) foi detectada em dois pacientes durante o seguimento (11,1%). Observamos melhora significativa em todos os parâmetros relevantes aos três meses de acompanhamento: IPSS: 15,7 vs. 2,9; qualidade de vida: 5,2 vs. 1,0); PSA: 11,4 vs. 1,82 ng/mL; pico de fluxo urinário: 7,45 vs. 18,6 mL/s); volume prostático: 252,4 vs. 151,6 cmA EAP em pacientes com próstata muito aumentada foi segura e eficaz, com significativas melhoras clínica, urodinâmica e imaginológica. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|